Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA)
India
· Delayed Price · Currency is INR
1,780.00
+2.75 (0.15%)
Nov 21, 2024, 3:29 PM IST
SUNPHARMA Revenue
Sun Pharmaceutical Industries had revenue of 132.91B INR in the quarter ending September 30, 2024, with 9.01% growth. This brings the company's revenue in the last twelve months to 503.08B, up 8.64% year-over-year. In the fiscal year ending March 31, 2024, Sun Pharmaceutical Industries had annual revenue of 484.97B with 10.51% growth.
Revenue (ttm)
503.08B
Revenue Growth
+8.64%
P/S Ratio
8.48
Revenue / Employee
11.70M
Employees
43,000
Market Cap
4,270.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 484.97B | 46.11B | 10.51% |
Mar 31, 2023 | 438.86B | 52.31B | 13.53% |
Mar 31, 2022 | 386.54B | 51.56B | 15.39% |
Mar 31, 2021 | 334.98B | 6.61B | 2.01% |
Mar 31, 2020 | 328.38B | 37.72B | 12.98% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSun Pharmaceutical Industries News
- 9 days ago - Nifty 50 top gainers today on 12 November: Trent, Infosys and Sun Pharmaceutical lead the charge - Business Upturn
- 17 days ago - Sun Pharmaceutical’s market cap falls ₹16,816 crore as shares decline 3.92% - Business Upturn
- 17 days ago - Sun Pharmaceutical shares decline nearly 5% as US court blocks LEQSELVI launch - Business Upturn
- 17 days ago - Nomura maintains neutral on Sun Pharma with slight downside, sets target price at Rs 1,850 - Business Upturn
- 17 days ago - Stocks to watch today on November 4: InfoEdge, NCC, Apollo Hospitals, Sun Pharma and more - Business Upturn
- 24 days ago - Sun Pharma profit up 28% on higher sales - The Times of India
- 24 days ago - Sun Pharma shares rise nearly 3% post Q2 results; revenue grows 9% YoY to ₹13,291 crore, net profit jumps 27.5% - Business Upturn
- 24 days ago - Sun Pharma Q2 FY25 Results Revenue grows 9%% YoY to ₹13,291.39 crore, Net Profit jumps 27.5% YoY to ₹3,040.1 crore - Business Upturn